Gene · 1398
Papers2,784
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,784
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A Novel Gemcitabine-Resistant Gallbladder Cancer Model Provides Insights into Molecular Changes Occurring during Acquired Resistance. | Int J Mol Sci | 2023 | 37108401 | PubTator, text mining | PubMed |
| Cysteine-rich receptor-like protein kinases: emerging regulators of plant stress responses. | Trends Plant Sci | 2023 | 37105805 | PubTator, text mining | PubMed |
| Understanding Nephrotic Syndrome Using Kidney Transcriptome Profiling and Computational Studies. | Kidney360 | 2023 | 37103957 | PubTator, text mining | PubMed |
| Gab2 plays a carcinogenic role in ovarian cancer by regulating CrkII. | J Ovarian Res | 2023 | 37085900 | PubTator, text mining | PubMed |
| CSF2 upregulates CXCL3 expression in adipocytes to promote metastasis of breast cancer via the FAK signaling pathway. | J Mol Cell Biol | 2023 | 37073091 | PubTator, text mining | PubMed |
| Outbreak report of polymyxin-carbapenem-resistant Klebsiella pneumoniae causing untreatable infections evidenced by synergy tests and bacterial genomes. | Sci Rep | 2023 | 37069157 | PubTator, text mining | PubMed |
| Uncovering a novel role of focal adhesion and interferon-gamma in cellular rejection of kidney allografts at single cell resolution. | Front Immunol | 2023 | 37063857 | PubTator, text mining | PubMed |
| Clinical and Genomic Evolution of Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infections over Two Time Periods at a Tertiary Care Hospital in South India: A Prospective Cohort Study. | Infect Dis Ther | 2023 | 37062023 | PubTator, text mining | PubMed |
| MiR-30 Family: A Novel Avenue for Treating Bone and Joint Diseases? | Int J Med Sci | 2023 | 37057210 | PubTator, text mining | PubMed |
| MACC1-induced migration in tumors: Current state and perspective. | Front Oncol | 2023 | 37051546 | PubTator, text mining | PubMed |
| Role of CD34 in inflammatory bowel disease. | Front Physiol | 2023 | 37051017 | PubTator, text mining | PubMed |
| Extracellular Vesicles as Potential Bladder Cancer Biomarkers: Take It or Leave It? | Int J Mol Sci | 2023 | 37047731 | PubTator, text mining | PubMed |
| Phase I Study of a Combination of Fluvastatin and Celecoxib in Children with Relapsing/Refractory Low-Grade or High-Grade Glioma (FLUVABREX). | Cancers (Basel) | 2023 | 37046681 | PubTator, text mining | PubMed |
| High Throughput Fluorescence-Based In Vitro Experimental Platform for the Identification of Effective Therapies to Overcome Tumour Microenvironment-Mediated Drug Resistance in AML. | Cancers (Basel) | 2023 | 37046649 | PubTator, text mining | PubMed |
| The Role of cMET in Gastric Cancer-A Review of the Literature. | Cancers (Basel) | 2023 | 37046637 | PubTator, text mining | PubMed |
| Global-feature of autoimmune glomerulonephritis using proteomic analysis of laser capture microdissected glomeruli. | Front Immunol | 2023 | 37033921 | PubTator, text mining | PubMed |
| A transcriptomics approach to expand therapeutic options and optimize clinical trials in oncology. | Ther Adv Med Oncol | 2023 | 37025260 | PubTator, text mining | PubMed |
| Blood-based liquid biopsy: insights into early detection, prediction, and treatment monitoring of bladder cancer. | Cell Mol Biol Lett | 2023 | 37016296 | PubTator, text mining | PubMed |
| Analysis of circulating extracellular vesicle derived microRNAs in breast cancer patients with obesity: a potential role for Let-7a. | J Transl Med | 2023 | 37004031 | PubTator, text mining | PubMed |
| Shared peripheral blood biomarkers for Alzheimer's disease, major depressive disorder, and type 2 diabetes and cognitive risk factor analysis. | Heliyon | 2023 | 36994393 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1398/papers?page=9